Arpeggio builds technology to watch and learn how drugs work.
Arpeggio Bio has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Arpeggio Bio's investors include Khosla Ventures, Y Combinator, Fifty Years, Builders VC, Tencent.
Arpeggio Bio is headquartered in Boulder, United States.
Arpeggio builds technology to watch and learn how drugs work.
Arpeggio Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arpeggio Bio — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/arpeggio-bio. Accessed July 19, 2026.
VCBacked. (2025). Arpeggio Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/arpeggio-bio
{{cite web |title=Arpeggio Bio — Funding & Investors |url=https://www.vcbacked.co/company/arpeggio-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated